DFSV vs XBI
Dimensional US Small Cap Value ETF vs SPDR S&P Biotech ETF
- • DFSV has the lower expense ratio at 0.30% vs 0.35% for XBI.
- • DFSV pays a higher dividend yield (1.38%).
Side-by-side metrics
| Metric | DFSV | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.30% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.38% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $7.92B | $10.73B |
YTD return | 16.91% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.99 | 1.10 |
P/E ratio | 14.42 | — |
Last price | $38.65 | $164.01 |
Inception | — | — |
Issuer | Dimensional | State Street |
DFSV top holdings
| BWA | BorgWarner Inc | 0.81% |
| KNX | Knight-Swift Transportation Holdings Inc Class A | 0.81% |
| DINO | HF Sinclair Corp | 0.80% |
| AMKR | Amkor Technology Inc | 0.75% |
| IVZ | Invesco Ltd | 0.70% |
| VSAT | Viasat Inc | 0.70% |
| ARW | Arrow Electronics Inc | 0.69% |
| WCC | WESCO International Inc | 0.65% |
| ZION | Zions Bancorp NA | 0.63% |
| COLB | Columbia Banking System Inc | 0.62% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About DFSV
DFSV (Dimensional US Small Cap Value ETF) is Systematic small-cap value strategy from Dimensional. Managed by Dimensional, the fund carries $7.9B in assets under management, an expense ratio of 0.30%, a dividend yield of 1.38%. Its largest holding is BorgWarner Inc (BWA), which represents 0.8% of the portfolio. Real Estate is the fund's largest sector exposure at 0.9%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.